Market Overview:
The global Radiopharmaceuticals In Nuclear Medicine Market is estimated to reach a value of US$ 11,978.6 Mn or Mn by 2022, exhibiting a steady compound annual growth rate (CAGR) of 8.0% over the forecast period of 2020-2027. Radiopharmaceuticals are a class of drugs used in nuclear medicine that contain radioactive isotopes. These drugs are administered to diagnose and treat various conditions, such as ... Read more
